e.l.f. Beauty (ELF) Form 144 Discloses 785-Share Sale; Prior June Sale Listed
Rhea-AI Filing Summary
Form 144 notice for e.l.f. Beauty, Inc. (ELF) reports a proposed sale of 785 restricted common shares by the named person through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $100,792.59 and an approximate sale date of 08/28/2025. The shares were acquired as restricted stock on 08/22/2024 and payment was recorded as not applicable.
The filing also discloses a prior sale by Maureen C. Watson of 3,875 common shares on 06/03/2025 generating gross proceeds of $445,625.00. The filer certifies no undisclosed material adverse information and includes the standard Rule 144 representations.
Positive
- Acquisition documented: 785 shares were acquired as restricted stock on 08/22/2024, providing clear provenance for the securities to be sold
Negative
- Insider selling: Proposed sale of 785 shares valued at $100,792.59 and a prior sale of 3,875 shares on 06/03/2025 for $445,625.00, which may be viewed negatively by some investors
Insights
TL;DR: Insider selling a modest number of shares; size and timing appear routine, likely limited market impact.
The Form 144 shows a proposed sale of 785 restricted shares valued at $100,792.59 and a recent sale of 3,875 shares with $445,625 gross proceeds. For a public company, these sizes are relatively small and executed through a major broker, suggesting routine liquidity by an insider rather than a signal of company-wide issues. The filing includes acquisition details confirming the shares were issued as restricted stock on 08/22/2024, which explains the timing of a Rule 144 filing once eligible to sell.
TL;DR: Disclosure aligns with Rule 144 requirements; representation of no undisclosed adverse information is standard and included.
The notice contains the required elements: class of securities, broker name and address, number of shares, market value, acquisition date and nature (restricted stock), and prior sales over the past three months. The signer affirms absence of undisclosed material adverse information, which is the standard certification for Rule 144 filings. No governance concerns are evident from the data provided alone.